We use cookies to help improve your experience. You can learn more by reading our Privacy Policy. By continuing to use our Site you agree to the terms of our policy. View Privacy Policy

Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. shares Americares mission to provide urgently needed relief to people affected by disasters around the globe. The company and its employees have helped us maintain the expertise and capabilities necessary to launch emergency responses swiftly and effectively.  

Comprehensive Compassion

Alexion has been an engaged partner to Americares since 2001. Following the 9/11 terrorist attacks, the company contributed to our Heroes Fund to support the family members of New York City firefighters, police officers and Port Authority employees who lost their lives. Since then, Alexion and its employees have supported responses to several specific disasters including the Pacific earthquake and tsunami in 2011, Hurricane Sandy in 2012, the earthquake in Nepal in 2015, flooding in India in 2017 and Hurricanes Harvey, Irma and Maria during the 2017 hurricane season.

Partner in Emergency Response

Alexion is an Americares Emergency Response Partner, providing key resources that allow us to maintain a response platform of medicines, supplies and emergency response experts. Thanks to Alexion and the other members of the AERP, when disasters strike, Americares can launch robust responses at a moment’s notice, delivering critical medicines and emergency supplies virtually anywhere in the world.

About Alexion

Alexion Pharmaceuticals, Inc. is focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Established in 1992, the company has a global presence and serves patients in approximately 50 countries. Alexion aims to be the global leader in rare diseases by leveraging its 20+ years of expertise in complement biology and capabilities in hematology, nephrology, neurology and metabolic disorders to bring additional life-changing therapies to patients.